Related references
Note: Only part of the references are listed.LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
Translational Research in Neurology and Neuroscience 2011
Christine Klein et al.
ARCHIVES OF NEUROLOGY (2011)
Gastrointestinal Symptoms in Parkinson Disease: Clinical Aspects and Management
D. Salat-Foix et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2011)
Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations
Frank Soldner et al.
CELL (2011)
An Update on Gene Therapy in Parkinson's Disease
Jennifer Witt et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
Mansoureh Hakimi et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies
Michael A. Nalls et al.
LANCET (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
Klaus Seppi et al.
MOVEMENT DISORDERS (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease
Susan H. Fox et al.
MOVEMENT DISORDERS (2011)
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Zhihua Liu et al.
NATURE IMMUNOLOGY (2011)
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation
Eugenie Mutez et al.
NEUROBIOLOGY OF AGING (2011)
Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials FOREWORD
Michael G. Schlossmacher et al.
BIOMARKERS IN MEDICINE (2010)
Parkinson's Disease and Motor Fluctuations
Vanessa K. Hinson
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Derek P. Narendra et al.
PLOS BIOLOGY (2010)
ZONISAMIDE: A NEW DRUG FOR PARKINSON'S DISEASE
M. Murata
DRUGS OF TODAY (2010)
Parkinson's Disease The Dual Hit Theory Revisited
Christopher H. Hawkes et al.
INTERNATIONAL SYMPOSIUM ON OLFACTION AND TASTE (2009)
Pluripotent stem cells as new drugs? The example of Parkinson's disease
Olivier Preynat-Seauve et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Can overexpression of parkin provide a novel strategy for neuroprotection in Parkinson's disease?
Ayse Ulusoy et al.
EXPERIMENTAL NEUROLOGY (2008)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Anthony H. V. Schapira
LANCET NEUROLOGY (2008)
Are Parkin patients particularly suited for deep-brain stimulation?
Ebba Lohmann et al.
MOVEMENT DISORDERS (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism
E. Moro et al.
NEUROLOGY (2008)
Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein
Shigeki Kato et al.
HUMAN GENE THERAPY (2007)
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson disease
Alexander Storch et al.
ARCHIVES OF NEUROLOGY (2007)
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
Christine Klein et al.
LANCET NEUROLOGY (2007)
'Rejuvenation' protects neurons in mouse models of Parkinson's disease
C. Savio Chan et al.
NATURE (2007)
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society- European Section. Part I: Early (uncomplicated) Parkinson's disease
M. Horstink et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
PINK1 protein in normal human brain and Parkinson's disease
S. Gandhi et al.
BRAIN (2006)
Genetics of Parkinson disease: paradigm shifts and future prospects
MJ Farrer
NATURE REVIEWS GENETICS (2006)
The genetics of Parkinson disease: implications for neurological care
C Klein et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers
PP Pramstaller et al.
ANNALS OF NEUROLOGY (2005)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Parkin disease: a phenotypic study of a large case series
NL Khan et al.
BRAIN (2003)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease
SA Oliveira et al.
ANNALS OF NEUROLOGY (2003)
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
H Shimura et al.
NATURE GENETICS (2000)
Association between early-onset Parkinson's disease and mutations in the parkin gene
CB Lücking et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
